title: Advances in novel influenza vaccines: a patent review.
abstract: The threat of a major human influenza pandemic such as the avian H5N1 or the 2009 new H1N1 has emphasized the need for effective prevention strategies to combat these pathogens. Although egg based influenza vaccines have been well established for a long time, it remains an ongoing public health need to develop alternative production methods that ensures improved safety, efficacy, and ease of administration compared with conventional influenza vaccines. This article is intended to cover some of the recent advances and related patents on the development of influenza vaccines including live attenuated, cell based, genomic and synthetic peptide vaccines.
authors.affiliation: Department of Global Medical Science, Sungshin Women's University, Seoul, 01133, Republic of Korea. jmsong@sungshin.ac.kr.
authors.forename: Jae-Min
authors.initials: JM
authors.lastname: Song
mesh_terms: D000818:Animals; D055808:Drug Discovery / Q000331:legislation & jurisprudence*; D006801:Humans; D007252:Influenza Vaccines / Q000235:genetics / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control* / Q000821:virology; D010330:Patents as Topic; D014611:Vaccination
chemical_list: D007252:Influenza Vaccines
keywords: attenuated; cell based; influenza vaccine; pandemic; recombinant proteins